CoChat

ETS-1 Transcription Factor Binds Cooperatively to the Palindromic Head to Head ETS-binding Sites of the Stromelysin-1 Promoter by Counteracting Autoinhibition

Open access
Baillat, David, Bègue, Agnès, Stéhelin, Dominique, Aumercier, Marc · 2002 · Journal of Biological Chemistry

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

Stromelysin-1 (matrix metalloproteinase-3) is a member of the matrix metalloproteinase family. Regulation of its gene expression is critical for tissue homeostasis. Patterns of increased co-expression of stromelysin-1 and ETS-1 genes have been observed in pathological processes. Stromelysin-1 promoter is transactivated by ETS proteins through two palindromic head to head ETS-binding sites, an unusual configuration among metalloproteinase promoters. By using surface plasmon resonance, electrophoretic mobility shift assay, and photo-cross-linking, we showed that full-length human ETS-1 (p51) binds cooperatively to the ETS-binding site palindrome of the human stromelysin-1 promoter, with facilitated binding of the second ETS-1 molecule to form an ETS-1.DNA.ETS-1 ternary complex. The study of N-terminal deletion mutants allowed us to conclude that cooperative binding implied autoinhibition counteraction, requiring the 245-330-residue region of the protein that is encoded by exon VII of the gene. This region was deleted in the natural p42 isoform of ETS-1, which was unable to bind cooperatively to the palindrome. Transient transfection experiments showed a good correlation between DNA binding and promoter transactivation for p51. In contrast, p42 showed a poorer transactivation, reinforcing the significance of cooperative binding for full transactivation. It is the first time that ETS-1 was shown to be able to counteract its own autoinhibition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m200088200

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1 ETS-1 specifically binds to the head to head EBS palindrome in a cooperative way. A , sensorgrams of a 200 nM ETS-1 injection over a Sensor Chip functionalized with 280 RU of WT, M1, and M2 oligonucleotides. The dotted line represents the sum of M1 and M2 sensorgrams. B , sensorgrams of a 200 nM ETS-1 injection over a Sensor Chip functionalized with 260 RU of WT, DR, IP, and M1 oligonucleotides (IP sensorgram comes from another Sensor Chip with the same amount of immobilized DNA). A and B , a flow cell functionalized with M1M2 oligonucleotides was used as a reference for nonspecific binding. C , gel shift assay. ETS-1 (4 pmol) was incubated with WT ( lanes 1 -4 ) or M1 ( lane 5 ) 32 P-labeled DNA probe (0.5 ng) in the absence ( lane 1 ) or in presence of WT (200 × , lane 2 ), M1M2 (200 × , lane 3 ), and (M1 400 × , lane 4 ) unlabeled competitors, WT ( lane 6 ), and M1 ( lane 7 ) free probes were loaded. D , photo-cross-linking assay resolved by SDS-PAGE. The same amount of ETS-1 (4 pmol) was incubated with increasing amounts (0.125, 0.25, 0.5, 1, and 2 ng) of WT ( lanes 2 -6 ) or M1 ( lanes 8 -12 ) 32 P-labeled DNA probe prior addition of photo-cross-linker (Ru(bpy) 3 Cl 2 , ammonium persulfate) and illumination. Lanes 1 and 7 are controls containing 2 ng of WT or M1 probe, respectively, cross-linked in the absence of ETS-1. E , same experiment as D , realized with an equimolar mixture of 32 P-labeled 15-mer oligonucleotides (referred to as 15-mer) corresponding to -223/ -209 and -208/ -194 sequences of the stromelysin-1 promoter as a probe (0.5, 1, and 2 ng, lanes 1 -3 ). Lane 4 is a control containing 2 ng of probe in absence of ETS-1. The arrow 1 indicates binary ETS-1 H18528 DNAcomplex. The arrow 2 indicates ternary ETS-1 H18528 DNA H18528 ETS-1 complex.
FIG. 1 ETS-1 specifically binds to the head to head EBS palindrome in a cooperative way. A , sensorgrams of a 200 nM ETS-1 injection over a Sensor Chip functionalized with 280 RU of WT, M1, and M2 oligonucleotides. The dotted line represents the sum of M1 and M2 sensorgrams. B , sensorgrams of a 200 nM ETS-1 injection over a Sensor Chip functionalized with 260 RU of WT, DR, IP, and M1 oligonucleotides (IP sensorgram comes from another Sensor Chip with the same amount of immobilized DNA). A and B , a flow cell functionalized with M1M2 oligonucleotides was used as a reference for nonspecific binding. C , gel shift assay. ETS-1 (4 pmol) was incubated with WT ( lanes 1 -4 ) or M1 ( lane 5 ) 32 P-labeled DNA probe (0.5 ng) in the absence ( lane 1 ) or in presence of WT (200 × , lane 2 ), M1M2 (200 × , lane 3 ), and (M1 400 × , lane 4 ) unlabeled competitors, WT ( lane 6 ), and M1 ( lane 7 ) free probes were loaded. D , photo-cross-linking assay resolved by SDS-PAGE. The same amount of ETS-1 (4 pmol) was incubated with increasing amounts (0.125, 0.25, 0.5, 1, and 2 ng) of WT ( lanes 2 -6 ) or M1 ( lanes 8 -12 ) 32 P-labeled DNA probe prior addition of photo-cross-linker (Ru(bpy) 3 Cl 2 , ammonium persulfate) and illumination. Lanes 1 and 7 are controls containing 2 ng of WT or M1 probe, respectively, cross-linked in the absence of ETS-1. E , same experiment as D , realized with an equimolar mixture of 32 P-labeled 15-mer oligonucleotides (referred to as 15-mer) corresponding to -223/ -209 and -208/ -194 sequences of the stromelysin-1 promoter as a probe (0.5, 1, and 2 ng, lanes 1 -3 ). Lane 4 is a control containing 2 ng of probe in absence of ETS-1. The arrow 1 indicates binary ETS-1 H18528 DNAcomplex. The arrow 2 indicates ternary ETS-1 H18528 DNA H18528 ETS-1 complex.CC-BY · From the PDF
FIG. 2 Surface plasmon resonance kinetic analysis of ETS-1 interaction with the EBS palindrome of the stromelysin-1 promoter. Representative set of sensorgrams illustrating the real time binding of various concentrations (7.25, 14.5, 29, and 58 nM) of ETS-1 to the M1 ( A ), M2 ( B ), and WT ( C ) stromelysin-1 promoter. M1M2 mutant was used as a reference for nonspecific binding. Analysis was performed as described under ' Materials and Methods. ' Kinetic models used and results are summarized in Tables III and IV, respectively.
FIG. 2 Surface plasmon resonance kinetic analysis of ETS-1 interaction with the EBS palindrome of the stromelysin-1 promoter. Representative set of sensorgrams illustrating the real time binding of various concentrations (7.25, 14.5, 29, and 58 nM) of ETS-1 to the M1 ( A ), M2 ( B ), and WT ( C ) stromelysin-1 promoter. M1M2 mutant was used as a reference for nonspecific binding. Analysis was performed as described under ' Materials and Methods. ' Kinetic models used and results are summarized in Tables III and IV, respectively.CC-BY · From the PDF
Image 3
CC-BY · From the PDF
Image 4
CC-BY · From the PDF
Image 5
CC-BY · From the PDF
FIG. 3 Organization of ETS-1 and its N-terminal deletion mutants. A , map of ETS-1 and its deletion mutants produced with T7 Impact System. B , secondary structure of the ETS-1 DBD ( 𝛂 -helices H1-H3 and 𝛃 -sheets S1-S4) and inhibitory regions (HI-1, HI-2, and H4). C , 15% acrylamide SDS-PAGE of ETS-1 and its various deletion mutants, silver-stained according to Ref. 59.
FIG. 3 Organization of ETS-1 and its N-terminal deletion mutants. A , map of ETS-1 and its deletion mutants produced with T7 Impact System. B , secondary structure of the ETS-1 DBD ( 𝛂 -helices H1-H3 and 𝛃 -sheets S1-S4) and inhibitory regions (HI-1, HI-2, and H4). C , 15% acrylamide SDS-PAGE of ETS-1 and its various deletion mutants, silver-stained according to Ref. 59.CC-BY · From the PDF
FIG. 4 Localization of the ETS-1 peptidic region implicated in the stromelysin-1 promoter binding cooperativity. As for Fig. 1 and Fig. 2, M1M2 oligonucleotide was used as a reference for nonspecific DNA binding. A , amount of protein bound to WT and M1 oligonucleotides at the equilibrium phase during a 200 nM injection of ETS-1 or its N-terminal deletion mutants, expressed in RU. B , representation of the ratio between the different proteins bound to WT oligonucleotide and M1 oligonucleotide for a 200 nM protein injection. RU for calculation were measured at the end of the injection at equilibrium phase. C , protein binding to WT and M1 oligonucleotides, expressed in fmol/mm 2 . D , gel shift assay. Same amount of ETS-1 or its N-terminal deletion mutants (4 pmol) was incubated with the WT or M1 32 P-labeled probe (0.5 ng).
FIG. 4 Localization of the ETS-1 peptidic region implicated in the stromelysin-1 promoter binding cooperativity. As for Fig. 1 and Fig. 2, M1M2 oligonucleotide was used as a reference for nonspecific DNA binding. A , amount of protein bound to WT and M1 oligonucleotides at the equilibrium phase during a 200 nM injection of ETS-1 or its N-terminal deletion mutants, expressed in RU. B , representation of the ratio between the different proteins bound to WT oligonucleotide and M1 oligonucleotide for a 200 nM protein injection. RU for calculation were measured at the end of the injection at equilibrium phase. C , protein binding to WT and M1 oligonucleotides, expressed in fmol/mm 2 . D , gel shift assay. Same amount of ETS-1 or its N-terminal deletion mutants (4 pmol) was incubated with the WT or M1 32 P-labeled probe (0.5 ng).CC-BY · From the PDF
FIG. 5 Comparison between binding of ETS-1 p51 and p42 isoforms to the EBS palindrome of the stromelysin-1 promoter. A , schematic organization of p51 and p42 isoforms of ETS-1. P represents a serine susceptible to be phosphorylated by CaMKII. B , gel shift assay. Equal amounts (4 pmol) of ETS-1 p51 ( lanes 1 -6 ) and ETS-1 p42 ( lanes 7 -12 ) isoforms are incubated with WT ( lanes 1 -3 and 7 -9 ) or M1 ( lanes 4 -6 and 10 -12 ) 32 P-labeled oligonucleotides (0.5 ng) in the presence of increasing amounts of unlabeled competitor (50 × lanes 2 , 5 , 8 , and 11 , and 200 × lanes 3 , 6 , 9 , and 12 ). C , gel shift assay. The same amount (4 pmol) of ETS-1 p42 was incubated with WT ( lane 1 ), M1 ( lane 2 ), M2 ( lane 3 ), and WT + 4 ( lane 4 ) 32 P-labeled probes (0.5 ng). D , SPR experiment. Ratio of protein bound to WT and M1 or WT and M2 oligonucleotides during the equilibrium phase of a 100 nM p51 or p42 injection. E , variation of the previous ratios as a function of the analyte ( Œ , p51, or f , p42) concentration (75, 100, 150, and 200 nM). The arrow 1 corresponds to the binary p42 H18528 DNA complex, and arrow 2 to the ternary p42 H18528 DNA H18528 p42 complex, and the arrow * to a complex formed with a minor contaminant.
FIG. 5 Comparison between binding of ETS-1 p51 and p42 isoforms to the EBS palindrome of the stromelysin-1 promoter. A , schematic organization of p51 and p42 isoforms of ETS-1. P represents a serine susceptible to be phosphorylated by CaMKII. B , gel shift assay. Equal amounts (4 pmol) of ETS-1 p51 ( lanes 1 -6 ) and ETS-1 p42 ( lanes 7 -12 ) isoforms are incubated with WT ( lanes 1 -3 and 7 -9 ) or M1 ( lanes 4 -6 and 10 -12 ) 32 P-labeled oligonucleotides (0.5 ng) in the presence of increasing amounts of unlabeled competitor (50 × lanes 2 , 5 , 8 , and 11 , and 200 × lanes 3 , 6 , 9 , and 12 ). C , gel shift assay. The same amount (4 pmol) of ETS-1 p42 was incubated with WT ( lane 1 ), M1 ( lane 2 ), M2 ( lane 3 ), and WT + 4 ( lane 4 ) 32 P-labeled probes (0.5 ng). D , SPR experiment. Ratio of protein bound to WT and M1 or WT and M2 oligonucleotides during the equilibrium phase of a 100 nM p51 or p42 injection. E , variation of the previous ratios as a function of the analyte ( Œ , p51, or f , p42) concentration (75, 100, 150, and 200 nM). The arrow 1 corresponds to the binary p42 H18528 DNA complex, and arrow 2 to the ternary p42 H18528 DNA H18528 p42 complex, and the arrow * to a complex formed with a minor contaminant.CC-BY · From the PDF
Image 9
CC-BY · From the PDF
Image 10
CC-BY · From the PDF
Image 11
CC-BY · From the PDF
Image 12
CC-BY · From the PDF
Image 13
CC-BY · From the PDF
FIG. 7 Activation of the stromelysin-1 promoter by ETS-1 p51 and p42 isoforms. A , reporter gene constructs used for the transient transactivation assay. The -478/ + 4 region of the WT and mutant stromelysin-1 promoters was cloned into a pGL3basic vector, and LUC represents the luciferase reporter gene. B , transient transfection assays are realized using HEK293 cells at 60 -80% confluence. 250 ng of each luciferase reporter vector were co-transfected with 250 ng of either p51 or p42 eukaryotic expression vector. Luciferase activities obtained were expressed as a percentage of the WT promoter activity co-transfected with the p51 expression vector (3.9-fold). Exact percentages are indicated on top of the bars. Results are the average of two representative experiments done in triplicate. C , Western blot analysis of HEK293 cell lysates after transfection with pSG5 ( lane 1 ), pSG5-p51 ( lane 2 ), and pSG5-p42 ( lane 3 ). The primary antibody used is directed against ETS-1 DNA binding domain (C-20, Santa Cruz Biotechnology).
FIG. 7 Activation of the stromelysin-1 promoter by ETS-1 p51 and p42 isoforms. A , reporter gene constructs used for the transient transactivation assay. The -478/ + 4 region of the WT and mutant stromelysin-1 promoters was cloned into a pGL3basic vector, and LUC represents the luciferase reporter gene. B , transient transfection assays are realized using HEK293 cells at 60 -80% confluence. 250 ng of each luciferase reporter vector were co-transfected with 250 ng of either p51 or p42 eukaryotic expression vector. Luciferase activities obtained were expressed as a percentage of the WT promoter activity co-transfected with the p51 expression vector (3.9-fold). Exact percentages are indicated on top of the bars. Results are the average of two representative experiments done in triplicate. C , Western blot analysis of HEK293 cell lysates after transfection with pSG5 ( lane 1 ), pSG5-p51 ( lane 2 ), and pSG5-p42 ( lane 3 ). The primary antibody used is directed against ETS-1 DNA binding domain (C-20, Santa Cruz Biotechnology).CC-BY · From the PDF
FIG. 8 Proposed model for ETS-1 cooperative binding to the stromelysin-1 promoter. It was based on kinetic and equilibrium analyses of ETS-1 interaction with the EBS palindrome of the stromelysin-1 promoter and on ETS-1 known structure and binding mechanism. N and C represent the N-terminal and C-terminal part of ETS-1, respectively. We propose that after binding to DNA (first step corresponding to ka 1 and kd 1 parameters), the first ETS-1 molecule facilitates the binding of the second one by positioning and helping it to reach its uninhibited state through a contact involving the exon VII-encoded region (second step corresponding to ka 2 and kd 2 ). The intermediary state where the first ETS-1 molecule contacts the second one before the complete formation of the ternary complex is represented by square brackets . After formation of the ternary complex, ETS-1 molecules are able to adopt a relaxed conformational state (last step corresponding to ka 3 and kd 3 ). We propose it to be a conformational change between the exon VII-encoded regions that were implicated in the previous step and could rearrange once the ternary complex is formed.
FIG. 8 Proposed model for ETS-1 cooperative binding to the stromelysin-1 promoter. It was based on kinetic and equilibrium analyses of ETS-1 interaction with the EBS palindrome of the stromelysin-1 promoter and on ETS-1 known structure and binding mechanism. N and C represent the N-terminal and C-terminal part of ETS-1, respectively. We propose that after binding to DNA (first step corresponding to ka 1 and kd 1 parameters), the first ETS-1 molecule facilitates the binding of the second one by positioning and helping it to reach its uninhibited state through a contact involving the exon VII-encoded region (second step corresponding to ka 2 and kd 2 ). The intermediary state where the first ETS-1 molecule contacts the second one before the complete formation of the ternary complex is represented by square brackets . After formation of the ternary complex, ETS-1 molecules are able to adopt a relaxed conformational state (last step corresponding to ka 3 and kd 3 ). We propose it to be a conformational change between the exon VII-encoded regions that were implicated in the previous step and could rearrange once the ternary complex is formed.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Research works printed but not linked: 9

  1. Liu, Z., Ivanoff, A., and Klominek, J. (2001) Int. J. Cancer 91, 638 -643 · DOI · Paper page
  2. Dittmer, J., and Nordheim, A. (1998) Biochim. Biophys. Acta 1377, F1-F11
  3. Wernert, N., Gilles, F., Fafeur, V., Bouali, F., Raes, M. B., Pyke, C., Dupressoir, T., Seitz, G., Vandenbunder, B., and Stehelin, D. (1994) Cancer Res. 54, 5683-5688
  4. Seth, A., Robinson, L., Thompson, D. M., Watson, D. K., and Papas, T. S. (1993) Oncogene 8, 1783-1790
  5. Venanzoni, M. C., Robinson, L. R., Hodge, D. R., Kola, I., and Seth, A. (1996) Oncogene 12, 1199 -1204
  6. Buttice, G., Duterque-Coquillaud, M., Basuyaux, J. P., Carrere, S., Kurkinen, M., and Stehelin, D. (1996) Oncogene 13, 2297-2306
  7. Hodge, D. R., Robinson, L., Watson, D., Lautenberger, J., Zhang, X. K., Venanzoni, M., and Seth, A. (1996) Oncogene 12, 11-18
  8. Higashino, F., Yoshida, K., Noumi, T., Seiki, M., and Fujinaga, K. (1995) Oncogene 10, 1461-1463
  9. Cowley, D. O. (2000) Regulation of Transcription Factors ETS-1 and ETS-2 by Autoinhibition and Phosphorylation, Ph.D. dissertation, University of Utah

Cited by

See all 88

Metadata

Authors
Baillat, D., Bègue, A., Stéhelin, D., & Aumercier, M.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
Aumercier, Marc
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2002-08
Volume
277
Issue
33
Pages
29386-29398
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1971048234
Cited by
84
References
59
Citations by year
2025: 2 · 2024: 1 · 2023: 3 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 1 · 2015: 5 · 2014: 7 · 2013: 4 · 2012: 4
FWCI
1.83
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Association pour la Recherche sur le Cancer
  • Centre National de la Recherche Scientifique
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Diffusion and Search Dynamics
Keywords
ETS1, stromelysin-1, matrix metalloproteinase-3, promoter transactivation, cooperative DNA binding, autoinhibition, transcription factor-DNA binding
MeSH terms
Base Sequence, Binding Sites, DNA, Genetic Vectors, Humans, Photochemistry, Protein Binding, Proto-Oncogene Proteins, Transcription Factors, Transcriptional Activation, Mutagenesis, Site-Directed, Matrix Metalloproteinase 3, Surface Plasmon Resonance, Electrophoretic Mobility Shift Assay, Proto-Oncogene Proteins c-ets, Proto-Oncogene Protein c-ets-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ETS-1 Transcription Factor Binds Cooperatively to the Palindromic Head to Head ETS-binding Sites of the Stromelysin-1 Promoter by Counteracting Autoinhibition. https://app.cochat.ai/papers/10.1074/jbc.m200088200
The paper
Baillat, D., Bègue, A., Stéhelin, D., & Aumercier, M. (2002). ETS-1 Transcription Factor Binds Cooperatively to the Palindromic Head to Head ETS-binding Sites of the Stromelysin-1 Promoter by Counteracting Autoinhibition. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m200088200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.